Page last updated: 2024-08-24

vamicamide and Hepatitis C, Chronic

vamicamide has been researched along with Hepatitis C, Chronic in 1 studies

*Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boujenah, JL; Bourlière, M; Cadranel, JF; Fontanges, T; Ouzan, D; Pol, S; Trepo, C1

Other Studies

1 other study(ies) available for vamicamide and Hepatitis C, Chronic

ArticleYear
Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational study.
    Gastroenterologie clinique et biologique, 2007, Volume: 31, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Compliance; Patient Satisfaction; Polyethylene Glycols; Prospective Studies; Pyridines; Recombinant Proteins; Self Administration; Surveys and Questionnaires

2007